Our Solutions   Tucaliv 50 mg Tablets

Tucaliv 50 mg Tablets

Tucaliv 50 mg tucatinib tablets - oncology medicine for HER2 therapies in India

*To be consumed as directed by physician.

Therapies:

Breast Cancer

Composition:

Tucatinib 50 mg

About Tucaliv 50 mg (Tucatinib) Tablets - Effective HER2-Positive Cancer Treatment

Tucaliv 50 mg Tablets contains Tucatinib 50 mg, a targeted anticancer medicine used for the treatment of HER2-positive advanced or metastatic breast cancer, including cases where cancer has spread to the brain. It is generally used in combination with trastuzumab and capecitabine in patients who have previously received HER2-directed therapies.

Tucaliv 50 mg tucatinib tablets - oncology medicine for HER2 therapies in India

*To be consumed as directed by physician.


Usage Instructions

  • Take Tucaliv 50 mg Tablets exactly as prescribed by your oncologist.
  • Do not stop or change the dose without consulting your doctor.
  • Regular monitoring, including liver function tests, may be required during treatment.

    • Benefits and Use

  • Tucaliv 50 mg Tablets is used for the treatment of HER2-positive advanced or metastatic breast cancer, including brain metastases.
  • It works by selectively blocking the HER2 receptor, a protein that promotes cancer cell growth and spread.
  • Tucatinib can penetrate the blood-brain barrier, helping control cancer that has spread to the brain.
  • When used alongside trastuzumab and capecitabine, it helps slow disease progression and improve treatment outcomes.

    • Safety Information

  • Alcohol: Avoid or limit alcohol consumption during treatment, as it may increase the risk of liver-related side effects.
  • Pregnancy: Unsafe during pregnancy. Effective contraception should be used during treatment and for at least 1 week after the last dose.
  • Breastfeeding: Breastfeeding is not recommended during treatment, as the medicine may pass into breast milk and harm the baby.
  • Driving: Use caution while driving or operating machinery, as this medicine may cause dizziness or fatigue in some patients.
  • Liver Disease: Use with caution in patients with liver disorders. Regular liver function tests are recommended during treatment.
  • Kidney Disease: Inform your doctor if you have kidney problems before starting treatment.
  • Lung Conditions: Use under medical supervision if you have lung-related conditions. Report any breathing difficulties or unusual symptoms to your doctor.

    • Ingredients

    Tucatinib 50mg

    How to Use

  • Take the tablet by mouth as directed by your doctor, usually twice daily (every 12 hours), with or without food.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break it.

    • Storage Information

    Store below 30°C in a cool, dry place away from direct sunlight and moisture.